Find your path to Jon
881 people in our graph can introduce you to Jon.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Pamela Klein to introduce you to Jon
You →Pamela · together at Sardona Therapeutics (2023) →Jon
Ask Jamie Chen to introduce you to Jon
You →Jamie · together at ロゴマーク:AIRNA →Jon
Ask Sam Okafor to introduce you to Jon
You →Sam · together at Medicxi →Jon
Sign up to find every way you can get introduced to Jon
- Your email: the people you already email who know Jon
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Jon
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Jon Edwards is a General Partner at Forbion who works on sourcing, evaluating, and structuring investments spanning company creation through early clinical development across therapeutic areas. He joined Forbion in 2025 and was previously a founding team member at Red Tree Venture Capital and Medicxi, with earlier roles at ClearView Healthcare Partners and Sepracor. He completed postdoctoral research at MIT and holds a PhD in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill.
Invests in
Biotech
Board director at Altesa BioSciences
Intro paths
In turn, Jon can intro founders to Altesa BioSciences's investors below.
Experience
- ForbionGeneral Partnercurrent2026 — presentBoston, Massachusetts, United States
- ForbionPartner2025 — 2026Boston, Massachusetts, United States
- Altesa BioSciences, Inc.Board Membercurrent2026 — presentBoston, Massachusetts, United States
- AIRNABoard Membercurrent2026 — presentBoston, Massachusetts, United States
- Spolia Therapeutics, Inc.Board Membercurrent2025 — presentBoston, Massachusetts, United States
- RXCELERATE LIMITEDBoard Membercurrent2023 — presentCambridge, England, United Kingdom
- CatalYm GmbHChair of the Board of Directors2024 — 2025Munich, Bavaria, Germany
- SynOx TherapeuticsBoard Member2024 — 2025Ireland
- Bicara TherapeuticsBoard Member2022 — 2024Cambridge, Massachusetts, United States
- Red Tree Venture CapitalBoard Representative2023San Francisco Bay Area
- Red Tree Venture CapitalManaging Director2020 — 2023San Francisco Bay Area
- Rondo TherapeuticsBoard of Directors2022 — 2023San Francisco Bay Area
- Biograph55Board of Directors2023San Francisco Bay Area
- Sardona TherapeuticsBoard of Directors2021 — 2023San Francisco Bay Area
- ExcellergyBoard of Directors2021 — 2023San Francisco Bay Area
- medicxiPartner2018 — 2020London Area, United Kingdom
- medicxiPrincipal2017 — 2018
- medicxiAssociate2016 — 2017Geneva, Geneva, Switzerland
- SYDNEXISBoard of Directors2018 — 2020San Diego County, California, United States
- Z FACTOR LIMITEDBoard of Directors2017 — 2020Greater Cambridge Area
- ULTRAHUMAN LIMITEDBoard of Directors2017 — 2020Greater Edinburgh Area
- Checkmate PharmaceuticalsBoard of Directors2020
- Phathom PharmaceuticalsBoard of Directors2019 — 2020
- Palladio Biosciences, Inc.Board of Directors2017 — 2020Newtown, PA
- Synthorx IncBoard of Directors2018San Diego County, California, United States
- Impact Biomedicines, Inc.Board of Directors2017 — 2018San Diego County, California, United States
- MITResearch Affiliate2013 — 2018Greater Boston
- MITPost Doctoral Research Associate2012 — 2013Greater Boston
- Index VenturesEarly Stage Investor2014 — 2016Geneva, Geneva, Switzerland
- ClearView Healthcare PartnersLife Science Strategy Consultant2013 — 2014
- University of North Carolina at Chapel HillPh.D. UNC Chapel Hill School of Medicine - Dept. Biochemistry and Biophysics2007 — 2012Chapel Hill, NC
Skills & more
+12 more
BiotechnologySAXSDrug DesignDrug TestingTissue CultureStructural BiologyPCRImmunohistochemistryStrategic PlanningELISANanoparticlesLifesciencesFrom Jon's professional profile.
Investments
Board seats
AiRNAAltesaSpoila
Investor
AltesaBicara TherapeuticsCatalYmCheckmate PharmaceuticalsExcellergyImpact BiomedicinesPalladio BiosciencesPhathom PharmaceuticalsRondo TherapeuticsRQ BioSynOx Therapeutics LtdSynthorxXenikos
Sources: the firm's website · curated public sources.
Colleagues at Forbion
Frequently asked questions
- Who is Jon Edwards?
- Jon Edwards is a General Partner at Forbion who works on sourcing, evaluating, and structuring investments spanning company creation through early clinical development across therapeutic areas. He joined Forbion in 2025 and was previously a founding team member at Red Tree Venture Capital and Medicxi, with earlier roles at ClearView Healthcare Partners and Sepracor. He completed postdoctoral research at MIT and holds a PhD in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill.
- Where does Jon Edwards work?
- Jon Edwards is General Partner at Forbion and Board director at Altesa BioSciences.
- What does Jon Edwards invest in?
- Jon Edwards invests in Biotech.
- What boards does Jon Edwards sit on?
- Jon Edwards holds tracked board seats at AiRNA, Altesa, Spoila.
- What companies has Jon Edwards invested in?
- Investments tracked here include Altesa, Bicara Therapeutics, CatalYm, Checkmate Pharmaceuticals, Excellergy, Impact Biomedicines, Palladio Biosciences, Phathom Pharmaceuticals, Rondo Therapeutics, RQ Bio, SynOx Therapeutics Ltd, Synthorx, and 1 more.
- Where did Jon Edwards go to school?
- Jon Edwards studied at The University of North Carolina at Chapel Hill (Doctor of Philosophy (Ph.D.), Biochemistry and Biophysics); University of Vermont (B.S, Biological Sciences); Massachusetts Institute of Technology (Post Doc).
Same school
Also attended The University of North Carolina at Chapel Hill543
+ 537 more
Also attended University of Vermont163
+ 157 more
Also attended Massachusetts Institute of Technology2,000
+ 1,994 more
Shared employers
Also worked at Biograph551
Also worked at medicxi22
+ 16 more























































